Caris Life Sciences, Inc. (CAI)
29.70
+2.20
(+8.00%)
USD |
NASDAQ |
Oct 09, 16:00
29.53
-0.17
(-0.57%)
After-Hours: 06:06
Caris Life Sciences Free Cash Flow (Quarterly) : 6.402M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.402M |
| March 31, 2026 | 22.53M |
| December 31, 2025 | 31.98M |
| September 30, 2025 | 55.33M |
| June 30, 2025 | 5.902M |
| Date | Value |
|---|---|
| March 31, 2025 | -34.03M |
| December 31, 2024 | -41.21M |
| September 30, 2024 | -71.26M |
| June 30, 2024 | -65.51M |
| March 31, 2024 | -75.66M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| CareDx, Inc. | 28.75M |
| Natera, Inc. | -8.636M |
| Myriad Genetics, Inc. | -11.50M |
| BioRestorative Therapies, Inc. | -3.808M |
| Exagen, Inc. | 3.445M |